Detalhe da pesquisa
1.
Chemical degrader enhances the treatment of androgen receptor-positive triple-negative breast cancer.
Arch Biochem Biophys
; 721: 109194, 2022 05 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35337811
2.
RNA-binding protein RNPC1: acting as a tumor suppressor in breast cancer.
BMC Cancer
; 14: 322, 2014 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-24884756
3.
Up-regulation of S100A16 expression promotes epithelial-mesenchymal transition via Notch1 pathway in breast cancer.
J Biomed Sci
; 21: 97, 2014 Oct 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-25287362
4.
Family history and risk of ductal carcinoma in situ and triple negative breast cancer in a Han Chinese population: a case-control study.
World J Surg Oncol
; 11: 248, 2013 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24083544
5.
Estrogen receptor (ER) was regulated by RNPC1 stabilizing mRNA in ER positive breast cancer.
Oncotarget
; 6(14): 12264-78, 2015 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-25881544
6.
The apoptotic effect of D Rhamnose ß-hederin, a novel oleanane-type triterpenoid saponin on breast cancer cells.
PLoS One
; 9(6): e90848, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24603880
7.
The anticancer effect and mechanism of α-hederin on breast cancer cells.
Int J Oncol
; 45(2): 757-63, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24842044
8.
Low serum creatine kinase levels in breast cancer patients: a case-control study.
PLoS One
; 8(4): e62112, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23614022